Iovance Stock Been Hammered: A Buying Opportunity or Lure for Risky Bets
Iovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
Millennials can benefit from specific wealth-building money habits. Discover strategies tailored for a successful financial future.
13,978 articlesIovance Biotherapeutics has shown dramatic swings, with recent gains masking a long history of volatility. This piece...
As the BNPL market matures, Affirm and Klarna face distinct paths to growth. This guide dives into business models, f...
The Points Guy releases its 2026 rankings, prioritizing value amid higher fuel costs and growing airline fees. See wh...
Housing advocates warn that proposed HUD funding reductions threaten affordability and housing supply as Congress con...
A top AI lab warns that its systems could begin self-improvement with minimal human input, triggering renewed calls f...
SpaceX's potential IPO has investors weighing a massive valuation against current profitability. This article breaks ...
Mega AI IPOs are lining up with trillion-dollar aspirations, but a contrarian view warns that upside may hinge on elu...
Ethereum rose off a brutal week, trading around the mid-1,700s as investors watch the ethereum price prediction: rati...
A high-conviction AI stock has turned heads as it climbs on stronger demand for AI infrastructure and software. This ...
After Friday’s tech retreat, a leading wall street strategist argues that cybersecurity presents the larger, longer-t...
A sharp job split shows healthcare added about 900,000 positions while other sectors shed jobs. Investors are reasses...
June brought a high-stakes move in AI infrastructure funding. Super Micro Computer announced a $7B equity financing p...